Clinical trials: Percutaneous Large Hole Vascular Closure
Percutaneous Large Hole Vascular Closure
PerQseal® Clinical Study
The objective is to evaluate the safety and effectiveness of the PerQseal vascular closure device system when used to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (arteriotomy up to 26 F) in…
- Trial name
- PATCH (NCT05653336)
- Testing
- PerQseal® Closure Device System
- Where
- 18 sites in United States, Germany
- Volunteers
- 149 people
- Sponsor
- Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
PerQseal® Impella Early Feasibility Study
The purpose of this Clinical Investigation Plan is to assess the initial feasibility results of the PerQseal® device, when used on this very specific Impella population.
- Trial name
- NCT04818541
- Testing
- PPCI, Cardiogenic shock
- Where
- 4 sites in United States
- Volunteers
- 19 people
- Sponsor
- Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
PerQseal®+ Early Feasibility Study
The objective of this Early Feasibility Study (EFS) is to evaluate the initial safety and preliminary effectiveness of the PerQseal®+ VCD in a small number of subjects when used to achieve hemostasis of common femoral…
- Trial name
- NCT05163548
- Testing
- PerQseal Plus Device
- Where
- 5 sites in United States
- Volunteers
- 15 people
- Sponsor
- Vivasure Medical Limited